Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Pharmacoepidemiology and Drug Safety
|
January 23, 2002
The role of databases in drug postmarketing surveillance
E M Rodriguez, J A Staffa, D J Graham
Biochemical Society Transactions
|
February 1, 1992
In vitro modelling of a mechanism of drug-related hypersensitivity
W R Rush, J H Mulvey, D J Graham
JAMA
|
December 5, 1997
Seizures reported with tramadol
L H Kahn, R J Alderfer, D J Graham
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1994
Temafloxacin syndrome: review of 95 cases
M D Blum, D J Graham, C A McCloskey
The American Surgeon
|
July 9, 1998
The association of intra-abdominal infection and abdominal wound dehiscence
D J Graham, J T Stevenson, C R McHenry
The Journal of Surgical Research
|
February 1, 1993
Colonoscopy for intermittent rectal bleeding: impact on patient management
D J Graham, T J Pritchard, A D Bloom
European Journal of Drug Metabolism and Pharmacokinetics
|
October 1, 1993
The comparative steady-state bioavailability of the active ingredients of Madecassol
W R Rush, G R Murray, D J Graham
Pharmacology & Toxicology
|
January 1, 1990
The mauve factor of porphyria, 3-ethyl-5-hydroxy-4,5-dimethyl-delta-3-pyrroline-2-one: effects on behaviour of rats and mice
M G Cutler, D J Graham, M R Moore
Journal of Chromatography
|
June 10, 1983
Simultaneous determination of nafimidone [1-(2-naphthoylmethyl)imidazole], a new anticonvulsant agent, and a major metabolite in plasma by high-performance liquid chromatography
D J Graham, J Eadie, B M Leadbetter, et al.
Biochemical Society Transactions
|
January 1, 1976
The effect of 4-ethyl-5-hydroxy-3,5-dimethyl-delta3-pyrrolin-2-one on porphyrin synthesis in the rat
D J Graham, M R Moore, G G Thompson, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Pharmacoepidemiology and Drug Safety
|
January 23, 2002
The role of databases in drug postmarketing surveillance
E M Rodriguez, J A Staffa, D J Graham
Biochemical Society Transactions
|
February 1, 1992
In vitro modelling of a mechanism of drug-related hypersensitivity
W R Rush, J H Mulvey, D J Graham
JAMA
|
December 5, 1997
Seizures reported with tramadol
L H Kahn, R J Alderfer, D J Graham
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1994
Temafloxacin syndrome: review of 95 cases
M D Blum, D J Graham, C A McCloskey
The American Surgeon
|
July 9, 1998
The association of intra-abdominal infection and abdominal wound dehiscence
D J Graham, J T Stevenson, C R McHenry
The Journal of Surgical Research
|
February 1, 1993
Colonoscopy for intermittent rectal bleeding: impact on patient management
D J Graham, T J Pritchard, A D Bloom
European Journal of Drug Metabolism and Pharmacokinetics
|
October 1, 1993
The comparative steady-state bioavailability of the active ingredients of Madecassol
W R Rush, G R Murray, D J Graham
Pharmacology & Toxicology
|
January 1, 1990
The mauve factor of porphyria, 3-ethyl-5-hydroxy-4,5-dimethyl-delta-3-pyrroline-2-one: effects on behaviour of rats and mice
M G Cutler, D J Graham, M R Moore
Journal of Chromatography
|
June 10, 1983
Simultaneous determination of nafimidone [1-(2-naphthoylmethyl)imidazole], a new anticonvulsant agent, and a major metabolite in plasma by high-performance liquid chromatography
D J Graham, J Eadie, B M Leadbetter, et al.
Biochemical Society Transactions
|
January 1, 1976
The effect of 4-ethyl-5-hydroxy-3,5-dimethyl-delta3-pyrrolin-2-one on porphyrin synthesis in the rat
D J Graham, M R Moore, G G Thompson, et al.
Page
of 8